25(OH) Vitamin D levels in premenopausal women with polycystic ovary syndrome and/or obesity

International Journal for Vitamin and Nutrition Research

Volumn 82, Issue 6, 2012, Pages 399-404

  Tsakova, Adelina D ^a   Gateva, Antoaneta T ^a   Kamenov, Zdravko A ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Insulin resistance; Obesity; PCOS; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; IMMUNOREACTIVE INSULIN;

ADULT; ARTICLE; BODY MASS; BULGARIA; CHEMILUMINESCENCE IMMUNOASSAY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PREMENOPAUSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 84880610877     PISSN: 03009831     EISSN: 16642821     Source Type: Journal    
DOI: 10.1024/0300-9831/a000137     Document Type: Article

References (22)

1. Wehr, E. et al. (2009) Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur. J. Endocrinol. 161 (4), 575-82.
2. Mai, X.M. et al (2012) Cross-Sectional and Prospective Cohort Study of Serum 25-Hydroxyvitamin D Level and Obesity in Adults: The HUNT Study. Am. J. Epidemiol. 2012; 15;1 75 (10): 1029-36.
3. Li, H.W. et al.(2011) Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism 60 (10), 1475-81.
4. Yildizhan, R. et al. (2009) Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch. Gynecol. Obstet. 280 (4), 559-63.
5. Hahn, S. et al. (2006) Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp. Clin. Endocrinol. Diabetes 114 (10), 577-83.
6. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). (2004) Hum. Reprod. 19 (1), 41-7.
7. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. (1995) World Health Organ. Tech. Rep. Ser. 854, 1-452.
8. Alberti, K.G. et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120 (16), 1640-5.
9. Holick, M.F. et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(7),1911-30.
10. Al-Sultan, A.I. et al.(2011) Vitamin D, parathyroid hormone levels and insulin sensitivity among obese young adult Saudis. Eur. Rev. Med. Pharmacol. Sci. 15 (2), 135-47.
11. Del Gobbo, L.C. et al. (2011) Serum 25-hydroxyvitamin D is not associated with insulin resistance or beta cell function in Canadian Cree. J. Nutr. 141 (2), 290-5.
12. Muscogiuri, G. et al. (2010) 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity 18 (10), 1906-10.
13. Ou, H.Y. et al. (2011) Interaction of BMI with vitamin D and insulin sensitivity. Eur. J. Clin. Invest. 41 (11), 1195-201.
14. Soares, M.J. et al. (2011) Vitamin D and parathyroid hormone in insulin resistance of abdominal obesity: cause or effect? Eur. J. Clin. Nutr. 65 (12), 1348-52.
15. Tidwell, D.K. and Valliant, M.W. (2011) Higher amounts of body fat are associated with inadequate intakes of calcium and vitamin D in African-American women. Nutr. Res. 31 (7), 527-36.
16. Rosenblum, J.L. et al. (2012) Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults. Am. J. Clin. Nutr. 95 (1), 101-8.
17. Vigil, P. et al. (2007) Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome. Hum. Reprod. 22 (11), 2974-80.
18. Homburg, R. (1996) Polycystic ovary syndrome-from gynaecological curiosity to multisystem endocrinopathy. Hum. Reprod. 11 (1), 29-39.
19. Ngo, D.T. et al. (2011) Determinants of insulin responsiveness in young women: impact of polycystic ovarian syndrome, nitric oxide, and vitamin D. Nitric Oxide 25, 326-330.
20. Mahmoudi, T. et al. (2010) Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertility and Sterility 93, 1208-1214.
21. Panidis, D. et al. (2005) Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clinical Chemistry 51, 1691-1697.
22. Lerchbaum, E. and Obermayer-Pietsch, B. (2012) Vitamin D and fertility: a systematic review. European Journal of Endocrinology 166, 765-778.